YPF-p treats PF by down-regulating the expression of TGF-β1 mRNA and improving the excessive aggregation of fibroblasts induced by TGF-β1, which reduces the expression of HYP, COL and a-SMA in lung tissue. The gene discussed is TGFB1; the disease is pemphigus foliaceus.